Literature DB >> 11799940

(99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study.

Iraj Khalkhali1, Janet K Baum, Javier Villanueva-Meyer, Steven L Edell, Laurence G Hanelin, Carlos E Lugo, Raymond Taillefer, Leonard M Freeman, Charles E Neal, Alice M Scheff, James L Connolly, Stuart J Schnitt, Mary J Houlihan, John S Sampalis, Stephen B Haber.   

Abstract

PURPOSE: To evaluate the accuracy of scintimammography as an adjunct to physical examination and mammography in the detection of breast cancer in women with dense and fatty breasts.
MATERIALS AND METHODS: A total of 558 women were prospectively enrolled from 42 centers in North America. Images were interpreted by readers blinded to the subjects' clinical history, mammographic findings, and other test results. The Breast Imaging Reporting and Data System classification was used to describe breast density. Parenchymal patterns of "heterogeneously dense" and "extremely dense" were used to classify breasts as dense, whereas "almost entirely fat" and "numerous vague densities" defined fatty breasts. Between-group differences were evaluated with the 2 test for categorical variables and Student t test for continuous variables. Accuracy of scintimammography was assessed against the core laboratory histopathologic evaluation, the standard. The 95% CIs around point estimates of sensitivity, specificity, and positive and negative predictive values were calculated with the normal approximation to the binomial distribution.
RESULTS: The analyses were based on 580 breasts with an abnormality; 276 (48%) breasts were dense and 228 had a malignant lesion. Diagnostic properties for scintimammography of fatty versus dense breasts were, respectively, sensitivity, 72% versus 70%; specificity, 80% versus 78%; positive predictive value, 72% versus 67%; negative predictive value, 81% versus 81%; and accuracy, 77% versus 75% (all not significant). Scintimammography led to similar and significant changes in the posttest likelihood of cancer for both dense and fatty breasts.
CONCLUSION: The diagnostic accuracy of scintimammography is not affected by breast density.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799940     DOI: 10.1148/radiol.2221010237

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Breast scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

3.  Molecular Imaging in Breast Cancer - Potential Future Aspects.

Authors:  Katja Pinker; Wolfgang Bogner; Stephan Gruber; Peter Brader; Siegfried Trattnig; Georgios Karanikas; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

4.  Evaluation of fully 3-D emission mammotomography with a compact cadmium zinc telluride detector.

Authors:  Caryl N Brzymialkiewicz; Martin P Tornai; Randolph L McKinley; James E Bowsher
Journal:  IEEE Trans Med Imaging       Date:  2005-07       Impact factor: 10.048

5.  Comparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms.

Authors:  Zongyi Gong; Mark B Williams
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

6.  Breast scintigraphy today: indications and limitations.

Authors:  Orazio Schillaci; John R Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-23       Impact factor: 9.236

7.  Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.

Authors:  B Bagni; A Franceschetto; A Casolo; M De Santis; I Bagni; F Pansini; C Di Leo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-09       Impact factor: 9.236

Review 8.  FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.

Authors:  K Scheidhauer; C Walter; M D Seemann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-06       Impact factor: 9.236

9.  99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.

Authors:  Zhonglin Liu; Gail D Stevenson; Harrison H Barrett; George A Kastis; Michel Bettan; Lars R Furenlid; Donald W Wilson; James M Woolfenden; Koon Yan Pak
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

10.  A (99m)Tc-labeled triphenylphosphonium derivative for the early detection of breast tumors.

Authors:  Zhixin Li; Marcos Lopez; Micaël Hardy; Donna M McAllister; Balaraman Kalyanaraman; Ming Zhao
Journal:  Cancer Biother Radiopharm       Date:  2009-10       Impact factor: 3.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.